Market closed

Grifols Class A/€GRF

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About Grifols Class A

Grifols SA, operating under the ticker GRF, is a biopharmaceutical company specialized in the production of plasma-derived medicines. Founded in 1940 and headquartered in Barcelona, Spain, Grifols is engaged in the diagnosis, prevention, and treatment of a variety of diseases, with a strong focus on immunology, hematology, and intensive care sectors. The company operates globally, leveraging advanced technologies and rigorous quality processes to provide essential medical products.

Ticker

€GRF
Sector
Health Care

Trading on

BME

Industry

Biotechnology
Headquarters
Barcelona, Spain

Employees

23,000
Website
www.grifols.com

Grifols Class A Metrics

BasicAdvanced
€5.5B
37.15
€0.24
0.70
-

€5.5B

0.7

€12.04

€6.36

2M

2.26

0.77

110.521

123.24

1.61%

2.87%

2.71%

37.152

0.856

1.03

-1.03

28.687

7.21%

11.57%

-23.28%

What the Analysts think about Grifols Class A

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Grifols Class A stock.

Grifols Class A Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Grifols Class A Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy €GRF

€

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Grifols Class A stock?

Grifols Class A (GRF) has a market cap of €5.5B as of January 15, 2025.

What is the P/E ratio for Grifols Class A stock?

The price to earnings (P/E) ratio for Grifols Class A (GRF) stock is 37.15 as of January 15, 2025.

Does Grifols Class A stock pay dividends?

No, Grifols Class A (GRF) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Grifols Class A dividend payment date?

Grifols Class A (GRF) stock does not pay dividends to its shareholders.

What is the beta indicator for Grifols Class A?

Grifols Class A (GRF) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.